AIM weekly movers: Futura Medical considering options

Predictive genetics company GENinCode (LON: GENI) says it knows of no reason for the recent share price rise. The interim results will be published on 30 September. The share price was above 5p, but it has fallen back to 3.85p, which is still 148% higher.

Renalytix (LON: RENX) has signed a collaboration agreement with Tempus AI which will help to accelerate the adoption of the company’s kidneyintelX.dkd test to help slow kidney disease. The test is for predicting “progressive decline in kidney function in type 2 diabetes patients with diagnosed chronic kidney disease stages 1-3b”. Polar Capital reduced its stake from 8.98% to 3.98%. The share price jumped 83.8% to 10.75p.

- Advertisement -

Adrian Crucefix has taken a 5.03% stake in Nativo Resources (LON: NTVO). The share price rose 61.5% to 0.525p.

Quadrise (LON: QED) has appointed Peter Borup as chief executive. He has a shipping background. Quadrise successfully completed proof-of-concept an emissions testing for MSAR and bioMSAR on Everllence 4-stroke engines. The share price improved 34.1% to 4.35p.  

FALLERS

Sexual health products developer Futura Medical (LON: FUM) says 2025 revenues will be much lower than expected and it has widened the strategic review to include all options to create shareholder value. US sales of Eroxon remain weak and there are stocks left from the original order. Other markets are also weaker than expected. The $2.5m milestone payment from Haleon for granting of a US patent has been delayed until next year. Full year revenues will be between £1.3m and £1.4m. Cash was £2.71m at the end of August 2025. This should last until January 2026. Cost savings are being made and funding sought. Interim results will be published on 30 September. The share price dived 41.7% to 5.245p.

- Advertisement -

Secure Property Development & Investment (LON: SPDI) is distributing the shares it owns in Arcona Property Fund to its shareholders. The record date was 15 September. The share price declined through the week and ended up down 41.2% to 2.5p.

Acoustic products supplier Autins Group (LON: AUTG) is suffering from volatile conditions in the automotive sector. In the five months to August 2025, revenues fell from £8m to £7.7m and the loss was reduced from £714,000 to £258,000. JLR is a major customer, and it has been hit by a cyber attack. JLR production stopped on 1 September and that will hold back Autins revenues. The share price fell 28.6% to 7.5p.

Geo Exploration (LON: GEO) has completed drilling at hole JUD001 at the Juno project and the equipment moved to JUD002. Drill core from JUD001 will be sent to a laboratory. The company has repaid a $270,000 loan from chief executive Omar Ahmad. The share price declined 23.8% to 0.32p.

Latest News

More Articles Like This